*Result*: Temporal robustness of biomarker-based classification algorithms for sepsis.
Original Publication: Berlin ; New York, Springer International.
Lancet Respir Med. 2023 Nov;11(11):965-974. (PMID: 37633303)
N Engl J Med. 2024 Dec 5;391(22):2133-2146. (PMID: 39774315)
Lancet Respir Med. 2014 Aug;2(8):611-20. (PMID: 24853585)
Crit Care Med. 2018 Jun;46(6):915-925. (PMID: 29537985)
Crit Care. 2023 Jul 20;27(1):292. (PMID: 37474944)
Crit Care Med. 2021 Jan 1;49(1):e63-e79. (PMID: 33165028)
Am J Respir Crit Care Med. 2024 Jul 15;210(2):155-166. (PMID: 38687499)
Nat Commun. 2024 May 30;15(1):4606. (PMID: 38816375)
Lancet Respir Med. 2017 Oct;5(10):816-826. (PMID: 28864056)
Trends Mol Med. 2014 Apr;20(4):195-203. (PMID: 24581450)
Am J Respir Crit Care Med. 2019 Apr 15;199(8):980-986. (PMID: 30365341)
Crit Care Med. 2003 Apr;31(4):1250-6. (PMID: 12682500)
Lancet Respir Med. 2018 Sep;6(9):691-698. (PMID: 30078618)
Lancet Respir Med. 2024 Apr;12(4):323-336. (PMID: 38408467)
Am J Respir Crit Care Med. 2025 Mar;211(3):347-356. (PMID: 39642348)
Intensive Care Med. 2023 Nov;49(11):1360-1369. (PMID: 37851064)
Lancet Respir Med. 2024 Apr;12(4):305-322. (PMID: 38142698)
Lancet Respir Med. 2016 Apr;4(4):259-71. (PMID: 26917434)
Nat Med. 2025 Dec;31(12):4084-4096. (PMID: 41028543)
Nat Med. 2025 Dec;31(12):4119-4130. (PMID: 41028542)
0 (Cytokines)
*Further Information*
*Purpose: Heterogeneity of the host response in sepsis hampers development of effective treatments. Several immunobiologically distinct subphenotypes (or endotypes) have been identified using data-driven analyses of single-timepoint biomarker data, but their temporal stability remains uncertain due to dynamic biology and statistical limitations.
Methods: We analyzed data from 345 sepsis patients across two ICU cohorts. 30 immune biomarkers were measured every 8 h for up to 7 days. Latent profile analysis was used to identify classes upon admission and re-classify patients at later timepoints. Temporal robustness was assessed by (1) inter-class transition rates, and (2) intra-class cohesion (regardless of label) using the Rand Index (RI).
Results: At ICU admission, three immune profiles were identified: profile A (149 patients, 43%) reflected adaptive immune activation (elevated IL-4, IL-5, RANTES, and GM-CSF); profile B (60 patients, 17%) a hyperinflammatory state (high IL-6, IL-8, IL-1Ra, and low protein C); and profile C (136 patients, 39%) broadly attenuated inflammation. By 48 h, the prevalences of A and B declined to 31% and 13%, while C increased to 56%. Inter-class transitions occurred most in patients assigned to A (41% of all 8-hourly transitions), compared to 39% and 22% for B and C. Intra-class cohesion across intervals was poor (median RI 65%, IQR 62-64%), indicating that patients classified together at admission did not remain consistently together.
Conclusion: Sepsis patients were frequently reclassified across immune profiles over short intervals, with approximately one-third of subgroup peers changing at each timepoint. This instability challenges the clinical utility of biomarker-derived endotypes.
(© 2025. The Author(s).)*
*Declarations. Conflicts of interest: All authors declare that they have no conflicts of interest.*